Le Lézard
Classified in: Health, Covid-19 virus
Subjects: WOM, VET, MAT

Advocates From 50 States to Participate in Federal Advocacy Day Hosted by RESOLVE: The National Infertility Association and American Society for Reproductive Medicine


MCLEAN, Va., May 19, 2020 /PRNewswire-PRWeb/ -- RESOLVE: The National Infertility Association and ASRM (the American Society for Reproductive Medicine) are partnering to host their annual Federal Advocacy Day as a virtual event on Wednesday, May 20, 2020. More than 400 advocates from all 50 states will meet virtually with members of Congress and their staff to discuss the physical, emotional, and financial impact of infertility and reproductive care.

"We are thrilled to host so many advocates from across the country who will proudly speak up for the tens of thousands of women and men in their states struggling to build their family," said Barbara Collura, President and CEO of RESOLVE. "While transforming Advocacy Day to a virtual event was the result of the COVID-19 pandemic, the very positive result is that we have increased participation and have wider representation this year. For the first time ever, advocates from all 50 states are participating in Advocacy Day!"

"ASRM's members, which include reproduction and infertility specialists, gynecologists, urologists, mental health professionals and others, are ready and excited to amplify the need for expanded access to reproductive and infertility care and a continued and growing investment in medical research by the National Institutes of Health and the National Institute of Child Health and Human Development. We look forward to seeing the impact of what is expected to be our most widely attended Advocacy Day yet," said Sean Tipton, ASRM Chief Advocacy, Policy and Development Officer.

More than 400 patients, physicians, and others who support the infertility community will meet with their Members of Congress. Advocates share their personal stories and ask their Members of Congress to support several key pieces of legislation that impact the infertility community, including:

"By sharing their own personal stories, our advocates demonstrate the true impact that could be made with the passage of several important pieces of legislation," added Collura.

For more information visit RESOLVE's 2020 Federal Advocacy Day Issues webpage.

-----------------------------------------

About RESOLVE: The National Infertility Association: Established in 1974, RESOLVE: The National Infertility Association is a non-profit organization with the only established, nationwide network mandated to promote reproductive health and to ensure equal access to all family building options for men and women experiencing infertility or other reproductive disorders. One in eight U.S. couples of childbearing age has trouble conceiving or carrying a pregnancy to term. RESOLVE addresses this public health issue by providing community to these women and men, connecting them with others who can help, empowering them to find resolution and giving voice to their demands for access to all family building options. For more information, visit http://www.RESOLVE.org.

About the American Society for Reproductive Medicine (ASRM): For almost a century, the American Society for Reproductive Medicine (ASRM) has been the global leader in multidisciplinary reproductive medicine research, ethical practice, and education. ASRM impacts reproductive care and science worldwide by creating funding opportunities for advancing reproductive research and discovery, by providing evidence-based education and public health information, and by advocating for reproductive health care professionals and the patients they serve. With members in more than 100 countries, the Society is headquartered in Washington, DC, with additional operations in Birmingham, AL. For more information, visit: http://www.asrm.org.

 

SOURCE RESOLVE: The National Infertility Association


These press releases may also interest you

at 07:08
Pulnovo Medical Limited, a globally recognized device pioneer in the treatment of Pulmonary Hypertension (PH) and Heart Failure (HF), is pleased to announce the successful initiation and first two patients enrollment for its global multicenter...

at 07:05
Bruker Corporation is pleased to announce the successful installation of a 1.2 GHz NMR spectrometer at the Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin, accepted in the second quarter of 2024. This ultra-high field NMR...

at 07:05
KORU Medical Systems, Inc. ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today...

at 07:05
Satellos Bioscience Inc. ("Satellos" or the "Company") , a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders, today announced preliminary results from a single case...

at 07:00
ThirtyFiveBio Limited,...

at 07:00
DRI Healthcare Trust (the "Trust"), a global leader in providing financing to advance innovation in the life sciences industry, has acquired a second royalty interest in the worldwide net sales of Xenpozyme (olipudase alfa) from HLS...



News published on and distributed by: